Document is current
Any future updates will be listed below
-
Authors
Wang, Jin-Xing
Zhang, Ling
Zhang, Peng-Wei
Yuan, Luo-Wei
Jiang, Jian
Cheng, Xiao-Hui
Zhu, Wei
Lei, Yong
Tian, Fa-Qing
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82200181)
School and Hospital Joint Fund of the Second Affiliated Hospital of Chinese University of Hong Kong, Shenzhen (YXLH2203)
Natural Science Foundation of Guangdong Province (2022A1515010128)
Guangdong Provincial Pearl River Talents Program (2021QN02Y438)
Natural Science Foundation of Shenzhen Municipality (JCYJ20230807141759001)
Special Fund Project for Economic and Technological Development of Longgang District, Shenzhen (LGKCYLWS2021000008)
- License Information
-
More Information
Article History
Received: 1 July 2024
Accepted: 26 December 2024
First Online: 6 January 2025
Declarations
:
: Bone marrow mononuclear cells (BMMCs) were collected from MM patients with approval from the Institute Research Ethics Committee (No. 2024014) of The Second Affiliated Hospital of the Chinese University of Hong Kong (Shenzhen), following the Helsinki Declaration. The animal experiments were approved by the Institutional Animal Care and Use Committee of The Chinese University of Hong Kong (Shenzhen) (No. CUHKSZ-AE2021011), following the WMA statement on animal use in biomedical research.
: Not applicable.
: The authors declare no competing interests.
